Taiwan FDA registration 5d80df078005d888e1d2c98e97376400
“CID” CRE8 EVO Sirolimus eluting Carbofilm coated coronary stent on rapid exchange balloon catheter
TW: “希艾迪” 擴立安依芙雷帕黴素冠狀動脈塗藥支架
Taiwan·Risk Class 3·MD·CID S.P.A.·Registered Oct 25, 2021 – Oct 25, 2026ActiveRegistration details
- Analysis ID
- 5d80df078005d888e1d2c98e97376400
- License Form
- Ministry of Health Medical Device Import No. 035007
- Customs Code
- DHA05603500700
Company information
- Manufacturer
- CID S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- CHAICO INVESTMENT CORPORATION
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- E Cardiovascular devices
- Product Type (Level 2)
- E0001 Cardiovascular stents
- Import Information
- Imports outside the borders;; Safety monitoring
Dates and status
- Registration Date
- Oct 25, 2021
- Expiry Date
- Oct 25, 2026
About this record
Access comprehensive regulatory information for “CID” CRE8 EVO Sirolimus eluting Carbofilm coated coronary stent on rapid exchange balloon catheter in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 5d80df078005d888e1d2c98e97376400 and manufactured by CID S.P.A.. The authorized representative in Taiwan is CHAICO INVESTMENT CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices